Nonprofit · EIN 52-1850793
AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY
Also known as ASBMT
Tax-exempt · CHICAGO, IL 60611
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $8,492,524 | $8,522,855 | -$30,331 | $13,933,403 | $4,777,473 | $9,155,930 |
| December 31, 2023 | 990 | $8,107,793 | $8,319,833 | -$212,040 | $11,968,853 | $3,162,510 | $8,806,343 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $2,769,640
- Program service revenue
- $4,838,798
- Investment income
- $481,651
- Royalties
- $400,429
- Net gain from sales of assets
- $194,336
- Other revenue
- $402,435
Expenses
- Grants and similar amounts paid
- $825,524
- Compensation of officers, directors and key employees
- $36,750
- Salaries, compensation and benefits (total)
- $36,750
- Professional fundraising fees
- $0
- Legal fees
- $19,286
- Accounting fees
- $47,000
- Travel
- $344,974
- Depreciation
- $18,000
- Program services (functional)
- $7,964,987
- Management and general (functional)
- $557,868
Balance sheet and other
- Total assets, start of year
- $11,968,853
- Total assets, end of year
- $13,933,403
- Total liabilities, end of year
- $4,777,473
- Net assets, end of year
- $9,155,930
- Land, buildings and equipment
- $65,580
- Publicly traded securities
- $10,949,427
- Net assets without donor restrictions
- $9,000,930
- Net assets with donor restrictions
- $155,000
- Gross unrelated business income
- $157,444
- Gross receipts
- $8,725,586
- Employees
- 0
- Volunteers
- 25
- Year formed
- 1993
- State of legal domicile
- IL
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DAVID PORTER MD VP | UNTIL 2/2024, THEN PRES ELECT Trustee or director, Officer | 3 | $30,500 |
| MARGARET MACMILLAN MD | VICE PRES AS OF 2/2024 Trustee or director, Officer | 3 | $2,750 |
| ALAN HANASH MD PHD | DIRECTOR Trustee or director | 3 | $2,000 |
| BETTY HAMILTON MD | DIRECTOR UNTIL 2/24 Trustee or director | 3 | $750 |
| RYOTARO NAKAMURA MD | DIRECTOR AS OF 2/24 Trustee or director | 3 | $750 |
| MIGUEL-ANGEL PERALES MD PRES | UNTIL 2/2024, THEN PAST PR Trustee or director, Officer | 3 | $0 |
| BRENDA SANDMAIER | PAST PRES UNTIL 2/2024 Trustee or director, Officer | 3 | $0 |
| COREY CUTLER MD PRES ELECT UNTIL | 2/2024, THEN PRESIDENT Trustee or director, Officer | 3 | $0 |
| MEHDI HAMADANI MD | SECRETARY Trustee or director, Officer | 3 | $0 |
| UDAY POPAT MD | TREASURER UNTIL 2/24 Trustee or director, Officer | 3 | $0 |
| ENEIDA NEMECEK MD | TREASURER AS OF 2/24 Trustee or director, Officer | 3 | $0 |
| NANDITA KHERA MD | DIRECTOR Trustee or director | 3 | $0 |
| DIANNA HOWARD MD | DIRECTOR Trustee or director | 3 | $0 |
| BRIAN BETTS MD | DIRECTOR UNTIL 2/24 Trustee or director | 3 | $0 |
| SUNG-YUN PAI MD | DIRECTOR Trustee or director | 3 | $0 |
7 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| KIRSTEN WILLIAMS | DIRECTOR UNTIL 2/24 Trustee or director | 3 | $0 |
| LORI MUFFLY MD | DIRECTOR Trustee or director | 3 | $0 |
| NIRALI SHAH MD | DIRECTOR Trustee or director | 3 | $0 |
| SOPHIE PACZESNEY MD | DIRECTOR AS OF 2/24 Trustee or director | 3 | $0 |
| CLAUDIO BRUNSTEIN MD | DIRECTOR AS OF 2/24 Trustee or director | 3 | $0 |
| ANDRE WILLIAMS | EXECUTIVE DIRECTOR UNTIL 8/24 Officer | 40 | $0 |
| HEATHER HURLEY | EXECUTIVE DIRECTOR AS OF 11/24 Officer | 40 | $0 |
990 for the year ended December 31, 2023: 21 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DAVID PORTER MD | VICE PRESIDENT AS OF 2/2023 Trustee or director, Officer | 3 | $30,000 |
| LESLIE KEAN | DIRECTOR UNTIL 2/2023 Trustee or director | 3 | $1,000 |
| BETTY HAMILTON MD | DIRECTOR Trustee or director | 3 | $750 |
| BRENDA SANDMAIER MD PRES | UNTIL 2/2023, THEN PAST PRESIDENT Trustee or director, Officer | 3 | $0 |
| MIGUEL-ANGEL PERALES MD VP | UNTIL 2/2023, THEN PRESIDENT Trustee or director, Officer | 3 | $0 |
| STELLA DAVIES | PAST PRESIDENT UNTIL 2/2023 Trustee or director, Officer | 3 | $0 |
| CORY CUTLER MD VP UNTIL | 2/2023, THEN PRESIDENT ELECT Trustee or director, Officer | 3 | $0 |
| AMRIAT KRISHNAN | SECRETARY UNTIL 2/2023 Trustee or director, Officer | 3 | $0 |
| MEHDI HAMADANI MD | SECRETARY AS OF 2/2023 Trustee or director, Officer | 3 | $0 |
| UDAY POPAT MD | TREASURER Trustee or director, Officer | 3 | $0 |
| NANDITA KHERA MD | DIRECTOR Trustee or director | 3 | $0 |
| DIANNA HOWARD MD | DIRECTOR Trustee or director | 3 | $0 |
| BRIAN BETTS MD | DIRECTOR Trustee or director | 3 | $0 |
| ALAN HANASH MD PHD | DIRECTOR Trustee or director | 3 | $0 |
| SUNG-YUN PAI MD | DIRECTOR Trustee or director | 3 | $0 |
| KIRSTEN WILLIAMS | DIRECTOR Trustee or director | 3 | $0 |
| LORI MUFFLY MD | DIRECTOR Trustee or director | 3 | $0 |
| NIRALI SHAH MD | DIRECTOR Trustee or director | 3 | $0 |
| SHALINI SHENOY | DIRECTOR UNTIL 2/2023 Trustee or director | 3 | $0 |
| ENEIDA NEMECEK | DIRECTOR UNTIL 2/2023 Trustee or director | 3 | $0 |
| ANDRE WILLIAMS | EXECUTIVE DIRECTOR Officer | 40 | $0 |
Address and contacts
- Address (IRS master file)
- 330 N WABASH AVE STE 2000, CHICAGO, IL 60611-7621
- In care of
- % BRUCE F MACKLER
- Principal officer (990 for 2024)
- ENEIDA NEMECEK, 330 N WABASH AVE 2000, CHICAGO, IL 60611
- Signed the 990
- ENEIDA NEMECEK, CURRENT TREASURER
- Phone
- (312) 321-6820
- Website
- WWW.ASTCT.ORG
- Return prepared by
- JM&M
Mission
ASTCT IS AN INTERNATIONAL PROFESSIONAL MEMBERSHIP ASSOCIATION OF MORE THAN 3000 PHYSICIANS, INVESTIGATORS AND OTHER HEALTH CARE PROFESSIONALS FROM MORE THAN 45 COUNTRIES, WHO ARE DEDICATED TO IMPROVING THE APPLICATION AND SUCCESS OF BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES. ASTCT STRIVES TO BE THE LEADING ORGANIZATION PROMOTING RESEARCH, EDUCATION AND CLINICAL PRACTICE IN THE FIELD THROUGH PROMOTING: COMPREHENSIVE DEVELOPMENT AND ADVANCEMENT OF THE FIELD OF BLOOD AND MARROW TRANSPLANTATION; EXCELLENCE IN CLINICAL CARE AND TREATMENT OUTCOMES THROUGH STANDARDS FOR BLOOD AND MARROW TRANSPLANTATION; INNOVATIVE RESEARCH TO ADVANCE THE SCIENCE AND CLINICAL APPLICATIONS OF OTHER CELLULAR THERAPIES; AND, RAPID DISSEMINATION OF BASIC AND CLINICAL BMT RESEARCH FINDINGS WITHIN THE MEDICAL FIELD AND TO THE GENERAL PUBLIC.
Program accomplishments
- ANNUAL MEETING - ASTCT TYPICALLY HOLDS A GENERAL MEETING WITH THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH ("CIBMTR"), WHERE ADMINISTRATORS, CLINICIANS, DATA MANAGER/CLINICAL RESEARCH PROFESSIONALS, FELLOWS IN TRAINING, INVESTIGATORS, LABORATORY TECHNICIANS, MEDICAL DOCTORS, NURSES, NURSE PRACTITIONERS, PHARMACISTS, PHYSICIAN ASSISTANTS, AND OTHER ALLIED HEALTH PROFESSIONALS BENEFIT FROM A FULL SCIENTIFIC PROGRAM; ADDRESSING THE MOST TIMELY ISSUES IN HEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY.Expenses $2,539,231 · revenue $2,327,892
- EDUCATION AND CONFERENCES - ASTCT PROVIDES FOCUSED EDUCATION TO IMPROVE RESEARCH, PATIENT OUTCOMES, AND FOSTER PROFESSIONAL DEVELOPMENT THROUGH DIVERSE OUTLETS AND OPPORTUNITIES.Expenses $2,001,001 · grants $4,050 · revenue $562,583
- OTHER PROGRAMS - THROUGHOUT THE YEAR, ASTCT OFFERS SPONSORSHIPS IN SUPPORT OF VARIOUS FUNCTIONS, INCLUDING ITS CONTENT HUB. SPONSORSHIP ARE RECOGNIZED RATABLY OVER THE APPLIABLE PERIOD. ASTCT ALSO RECEIVES A LIMITED AMOUNT OF REVENUES FROM ACTIVITIES, WHICH ARE RECOGNIZED AT A POINT IN TIME IN WHICH THE RELATED PERFORMANCE OBLIGATIONS ARE FULFILLED.Expenses $666,903 · grants $55,721 · revenue $250,763
- JOURNAL AND PUBLICATIONS - ASTCT RECEIVES ROYALTIES ON ADVERTISEMENT SALES AND OTHER SOURCES OF REVENUE ASSOCIATED WITH ITS JOURNAL, TRANSPLANTATION AND CELLULAR THERAPY, AS WELL AS CERTAIN EDITORIAL SUBSIDIES, UNDER A COLLABORATIVE ARRANGEMENT WITH ELSEVIER, INC.Expenses $542,978 · grants $15,753 · revenue $383,009
- MEMBERSHIP - ASTCT MEMBERS SPAN THE ENTIRE FIELD OF TRANSPLANTATION AND CELLULAR THERAPY - FROM BASIC SCIENCE RESEARCH TO DIRECT PATIENT CARE. ASTCT OFFERS A VARIETY OF MEMBERSHIP TYPES; INCLUDING AFFILIATE, JOINT, ASSOCIATE, HONORARY, IN-TRAINING, INTERNATIONAL, AND INSTITUTIONAL.Expenses $730,148 · revenue $373,670
- POLICY AND LEGISLATIVE - ASTCT PROUDLY ADVOCATES ON BEHALF OF ITS MEMBERS AND PATIENTS BY ENGAGING WITH GOVERNMENT LEADERS ON CAPITOL HILL AND SUBMITTING RESPONSES TO IMPORTANT LEGISLATIVE AND POLICY CHANGES. ASTCT BELIEVES THAT ADVOCACY IS A KEY COMPONENT IN SERVING PATIENTS BY HELPING THEM TO ACCESS SOME OF THE MOST INNOVATIVE LIFESAVING TREATMENTSExpenses $669,676
- INDUSTRY SUPPORT - ASTCT SPONSORS "NEW INVESTIGATOR AWARDS" AS PART OF ITS INDUSTRY RELATION PROGRAM DESIGNED TO ENCOURAGE CLINICAL AND/OR LABORATORY RESEARCH BY YOUNG INVESTIGATORS IN THE FIELD OF BLOOD AND MARROW TRANSPLANTATION, AND/OR CELL THERAPY.Expenses $815,050 · grants $750,000 · revenue $783,437
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 52-1850793
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1994
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H20Z)
- Assets (IRS master file)
- $13,933,403
- Income (IRS master file)
- $8,725,586
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $8,492,524 | $8,522,855 | $13,933,403 | XML |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $8,107,793 | $8,319,833 | $11,968,853 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $7,565,810 | $6,879,329 | $11,031,172 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1850793).
Questions about AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY
- What is the EIN of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY?
- The employer identification number (EIN) of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY is 52-1850793.
- Is AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1994.
- Are donations to AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY?
- The 990 for the year ended December 31, 2024 names ENEIDA NEMECEK.
- Who are the officers and directors of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY?
- The 990 for the year ended December 31, 2024 lists 22 people; 5 received compensation from the organization, the highest $30,500 (DAVID PORTER MD VP, UNTIL 2/2024, THEN PRES ELECT).
- How much revenue does AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $8,492,524, expenses of $8,522,855 and total assets of $13,933,403 at year end.
Other nonprofits in CHICAGO
- STANLEY MANNE CHILDRENS RESEARCH INSTITUTE EIN 36-3357005 · last filed 990 for 2025
- ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION EIN 02-0464400 · last filed 990 for 2024
- LUNGEVITY FOUNDATION EIN 36-4433410 · last filed 990 for 2025
- GATEWAY FOR CANCER RESEARCH INC EIN 73-1386920 · last filed 990 for 2025
- AMERICAN BURN ASSOCIATION INC EIN 36-2654533 · last filed 990 for 2024
- AMERICAN BOARD OF MEDICAL SPECIALTIES RESEARCH & EDUCATION F EIN 23-7304902 · last filed 990 for 2025
- CITIZENS UNITED FOR RESEARCH IN EPILEPSY EIN 36-4253176 · last filed 990 for 2025
- AMERICAN FOUNDATION FOR SURGERY OF THE HAND EIN 74-2428242 · last filed 990 for 2024